J. Rabbitt

发表

Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy.

M. Prados, V. Levin, M. Edwards, 1991, Journal of neurosurgery.

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.

M. Prados, M. McDermott, P. Gutin, 1998, International journal of radiation oncology, biology, physics.

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.

Susan M. Chang, M. Prados, M. McDermott, 2001, International journal of radiation oncology, biology, physics.

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.

Susan M. Chang, M. Berger, S. Vandenberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.

Susan M. Chang, M. Prados, K. Lamborn, 2004, International journal of radiation oncology, biology, physics.

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma.

Susan M. Chang, M. Prados, K. Lamborn, 2005, International journal of radiation oncology, biology, physics.

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma 1

Susan M. Chang, M. Prados, K. Lamborn, 2005 .

Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen

M. Prados, K. Lamborn, M. Edwards, 1997, Journal of Neuro-Oncology.

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas

M. Prados, R. Warnick, F. Doz, 2005, Journal of Neuro-Oncology.

Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.

M. Prados, K. Lamborn, W. Wara, 2000, Neuro-oncology.

33 Phase I study of OSI-774 alone or with temozolomide in patients with malignant glioma

Susan M. Chang, M. Prados, G. Fyfe, 2003 .

High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma

Susan M. Chang, M. Prados, M. Nicholas, 1998, Journal of Neuro-Oncology.

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma

Jennie W. Taylor, Susan M. Chang, M. Prados, 2017, Cancer Chemotherapy and Pharmacology.

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma 1 Neuro-Oncology

Susan M. Chang, M. Prados, K. Lamborn, 2005 .

Identifying the needs of brain tumor patients and their caregivers

Susan M. Chang, M. Prados, K. Lamborn, 2011, Journal of Neuro-Oncology.

PATIENT STUDY Identifying the needs of brain tumor patients and their caregivers

Susan M. Chang, N. Butowski, M. Polley, 2011 .

Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.

M. Prados, R. Warnick, M. Malec, 1996, American journal of clinical oncology.

A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.

Susan M. Chang, M. Prados, J. Costello, 2014, Neuro-oncology.

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas

Jennie W. Taylor, Susan M. Chang, P. Theodosopoulos, 2021, The Journal of clinical investigation.

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.

Susan Chang, Susan M. Chang, M. Prados, 2006, Neuro-oncology.

Quality of life in low-grade glioma patients receiving temozolomide.

Susan M. Chang, M. Prados, K. Lamborn, 2009, Neuro-oncology.

Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)

Susan M. Chang, M. Prados, K. Lamborn, 2008 .

Temozolomide in the treatment of recurrent malignant glioma

Susan M. Chang, M. Prados, P. Theodosopoulos, 2004, Cancer.

Attitudes toward fertility and fertility preservation in women with glioma.

Susan M. Chang, M. Prados, N. Butowski, 2018, Neuro-oncology practice.

Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.

M. Prados, K. Lamborn, W. Wara, 1999, International journal of radiation oncology, biology, physics.

Phase II study of salvage therapy with high-dose tamoxifen and oral etoposide for recurrent malignant glioma

Susan M. Chang, M. Prados, K. Lamborn, 2004 .

Selected complications in neuro-oncology patients.

J. Rabbitt, M. Page, 1998, Seminars in Oncology Nursing.

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.

Susan M. Chang, S. Vandenberg, M. Prados, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life in low-grade glioma patients receiving temozolomide.

Susan M. Chang, M. Prados, K. Lamborn, 2009, Neuro-oncology.